Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO2 Antikörper

Rockland 210-301-e59 IDO2 Reaktivität: Maus WB, ELISA, FM Wirt: Maus Monoclonal 1HC unconjugated
Rockland
Produktnummer ABIN1043821
Hersteller Produkt- Nr.: 210-301-e59
  • Target Alle IDO2 Antikörper anzeigen
    IDO2 (Indoleamine 2,3-Dioxygenase 2 (IDO2))
    Reaktivität
    • 53
    • 8
    • 7
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Maus
    Wirt
    • 55
    • 6
    • 1
    Maus
    Klonalität
    • 56
    • 6
    Monoklonal
    Konjugat
    • 26
    • 9
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser IDO2 Antikörper ist unkonjugiert
    Applikation
    • 51
    • 22
    • 16
    • 13
    • 13
    • 9
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Fluorescence Microscopy (FM)
    Hersteller Produkt- Nr.
    210-301-e59
    Hersteller
    Rockland
    Verwendungszweck
    IDO2 Antibody
    Kreuzreaktivität (Details)
    IDO2 antibody is specific for mouse IDO2 protein.
    Produktmerkmale
    Synonyms: mouse anti-IDO2 Antibody, Indoleamine 2,3-dioxygenase 2, Indol1, Indoleamine 2,3-dioxygenase-like protein 1, Indoleamine-pyrrole 2,3-dioxygenase-like protein 1, Ido-2, Ido 2, IDO2 antibody, mouse anti-IDO-2 antibody
    Aufreinigung
    Anti-IDO2 was purified from concentrated tissue culture supernate by Protein G chromatography followed by extensive dialysis against the buffer stated above.
    Sterilität
    Sterile filtered
    Immunogen

    Immunogen: Anti-IDO2 (MOUSE) Monoclonal Antibody was produced in mouse by repeated immunizations with complete mouse IDO2 protein followed by hybridoma development.

    Immunogen Type: Recombinant Protein

    Klon
    1HC
    Isotyp
    IgG2a kappa
    Top Product
    Discover our top product IDO2 Primärantikörper
  • Applikationshinweise

    Application Note: Anti-IDO2 antibody has been tested in western blot and is suitable for use in ELISA and IF. Specific conditions for reactivity should be optimized by the end user.

    Western Blot Dilution: 1:500-1:1500

    ELISA Dilution: 1:5000 - 1:50000

    IF Microscopy Dilution: 1:50-1:100

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0 mg/mL
    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
    Haltbarkeit
    12 months
  • Wolff, Driever, Erdlenbruch, Kortmann, Rutkowski, Pietsch, Parker, Metz, Gnekow, Kramm: "Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol." in: Cancer, Vol. 116, Issue 3, pp. 705-12, (2010) (PubMed).

    Metz, Duhadaway, Rust, Munn, Muller, Mautino, Prendergast: "Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase." in: Molecular cancer therapeutics, Vol. 9, Issue 6, pp. 1864-71, (2010) (PubMed).

  • Target
    IDO2 (Indoleamine 2,3-Dioxygenase 2 (IDO2))
    Andere Bezeichnung
    Ido2 (IDO2 Produkte)
    Hintergrund
    Background: Indoleamine 2,3-dioxygenase 2 (IDO2) is related to IDO1, and may play a role in T and B Cell Immunity. IDO2's role in immune regulation will be become clearer following the completion of genetic knock-out studies. IDO2 is expressed in a few select cell types and levels of protein expression appear to be very low, perhaps below the level of detection by IHC. Small-molecule inhibitors of indoleamine 2,3-dioxygenase (IDO) are currently being translated to clinic for evaluation as cancer therapeutics.
    Gen-ID
    209176
    NCBI Accession
    NP_666061
    UniProt
    Q8R0V5
Sie sind hier:
Kundenservice